|
| 
PACIFICTEXTILES(1382)
Analysis：
For the year ended 31 March 2024, revenue of Pacific Textiles Holdings Limited (01382) was HK$4665 million representing a decrease of 7.0% YoY. Profit attributable to equity holders of the Company was HK$167 million representing a decrease of 37.8% YoY. Showed a drop in profit attributable to shareholders, the fierce competition continued in the textile industry and customers` demand was weak. There were more factors which caused the downturn, inter alia, higher net interest expenses, preliminary operating loss incurred in the setting up stage of the new Vietnam factory, and the impairment loss relating to Teejay (an associate of the company). However, the share of the results of and the impairment loss relating to Teejay is non-cash in nature, and will not have any impact on the company`s cashflow and operation. Since the outlook of Teejay and believes in the continuous recovery of Sri Lanka`s economy and the business prospect of Teejay, the impairment loss for the coming financial year, if any, is estimated to be immaterial. It is worth noting that some of the company`s key customers had cleared their accumulated stock, resulting in rising demand. The issues of low utilization rate of Panyu Factory during the financial year has been eased from March 2024 and is on the rise in financial year of 2024/25. As orders to be placed with Panyu Factory by respective brand owners are expected to increase, the management is optimistic on gradual improvement in the financial performance of the Panyu Factory. As to the operation in South-east Asia region, the company`s factory in Hai Doung Province of Vietnam, has been operating at close to full capacity level and the management believes that the trend shall continue in 2024/25. With an additional factory in Vietnam, and the surge in production capacity and more flexible resources deployment, the revenue and the profit attributable to equity holders of the company is expected to show an upturn in 2024/25.
Strategy：
Buy-in Price: $1.68, Target Price: $1.85, Cut Loss Price: $1.56
|
|
Report Review of June 2024
Sectors: TMT, Semiconductors, Consumer & Healthcare （Eric Li） TMT, Semiconductors, Consumer, Healthcare (Eric Li)This month I released reports of Hengan (1044.HK). For the year ended 31 December 2023 (FY2023), Hengan's revenue increased by 5.1% to RMB23,768mn, above market expectation. During the year, operating profit increased significantly by 38.6% to RMB3,978mn (FY2022: RMB2,869mn). Although the depreciation of the Renminbi against the US dollar and the HK dollar during the year resulted in an operating foreign exchange loss after tax of RMB150mn, the loss was significantly reduced by about 83.6% compared with the operating FX loss before tax of RMB901mn in 2022. Therefore, profit attributable to shareholders of the Company was RMB2,801mn (FY2022: RMB1,925mn), representing a significant yoy increase of 45.5%. Excluding the operating FX loss after tax, profit attributable to shareholders of the Company increased by 4.3% yoy, mainly reflecting the improvement in the company's gross profit margin as a result of the decline in the cost of wood pulp and upgrades of products. Basic EPS was RMB2.415 (FY2022: RMB1.657), with full-year dividend RMB1.40 per share, unchanged yoy. During the year under review, raw material prices dropped in the second half of the year, leading to intensified market promotions and price competition. The decline in the price of wood pulp, the main raw material for tissue paper, in the second half of the year compared to the first half of the year, coupled with the robust growth in the company's upgraded products and premium product series resulted in a significant improvement in the gross profit of the tissue paper business. FY2023, the company's overall gross profit increased by 4.2% to RMB8,011mn (FY2022:RMB7,689mn). Although the gross profit margin was under pressure in the 1HFY2023, the overall gross profit margin for the full year still recorded at 33.7% (FY2022: 34.0%), almost consistent with last year. Gross profit the 2HFY2023 even significantly improved to 36.5% (2HFY2022: 32.8%). It is expected that in 2024, premium high margin products will continue to experience significant growth, leading to a continuous improvement in the gross profit margin. Despite a challenging operating environment, Hengan leverages its strong comprehensive competitive advantages and effective profit-focused sales strategies to continue expanding its market share and further solidify its robust business resilience. The company's three core business segments—tissue paper, sanitary napkins, and diapers—have maintained steady growth in revenue over the past two years. The decline in raw material prices in the second half of last year intensified industry marketing and price competition. However, the company prudently allocated promotional resources and continued to record significant growth in high-end, high-margin products. Gross profit margins are expected to remain stable. Hengan maintains a healthy financial condition with a significant improvement in its debt ratio to 69.8%, placing it in a net cash position. 
Click Here for PDF format...
|
|
|
|
| Stock Code |
H share
Price |
A share
Price |
H share
discount |
| | | |
|
Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.
If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.
版權所有， 翻印必究。
Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.
|
